Company intelligence
Gladstone Institutes
Science Overcoming Disease
About Gladstone Institutes
Gladstone's mission is to drive a new era of discovery in disease-oriented science and to mentor tomorrow’s leaders in an inspiring and diverse environment. Although Gladstone shares traits with other top life science organizations, we pride ourselves on taking uncommon scientific paths to overcoming disease. Our investigators are selected to become authorities in leading or creating new fields, and we work to provide them with resources to explore bold new thoughts, form effective scientific teams, and create or master emerging research technologies that accelerate progress—Gladstone’s special recipe for success that has yielded some of the most important biomedical advances of our time. Our three disease-focused institutes constitute the core of our discovery engine, but do not operate in isolation. We are seizing unprecedented opportunities for “convergence”—defined as the blending of intellectual and physical assets from multiple scientific disciplines and fields to speed the discovery process in our attack on unsolved health problems that affect almost every human family.
Verified activity
Signals from Gladstone Institutes
5 published signals
Research & Knowledge
Gladstone Institutes scientists Emma Dann and Ronghui Zhu stress-tested genes across 22 million human immune cells using real cells from real donors, not lab models.
Reported by Gladstone Institutes
Research & Knowledge
Gladstone Institutes scientists are using AI to find cures faster, with Geneformer and the thinking microscope being examples.
Reported by Gladstone Institutes
Research & Knowledge
Gladstone Institutes scientists, in collaboration with UC San Francisco, Stanford University, and Biohub, published a landmark study in Cell mapping 22 million human immune cells at unprecedented resolution, representing the largest contribution yet to Biohub's Billion Cells Project.
Reported by Gladstone Institutes
Research & Knowledge
Gladstone Institutes Assistant Investigator Michael Alexanian discusses his lab's work on two genes, BRD4 and MEOX1, that drive the chronic inflammation and fibrosis underlying heart failure.
Reported by Gladstone Institutes
Research & Knowledge
Gladstone Institutes researcher Lexi Schneider is developing a groundbreaking tool called TORCH to help scientists understand how the brain and body talk to each other.
Reported by Gladstone Institutes